Evolus Affirms FY2026 Sales Guidance of $327.000M-$337.000M vs $330.020M Est

Benzinga Newsdesk www.benzinga.com Negative 63.7%

Neg 63.7% Neu 0% Pos 0%

Evolus (NASDAQ:EOLS) affirms FY2026 sales outlook from $327.000 million-$337.000 million to $327.000 million-$337.000 million vs $330.020 million estimate.